Effectiveness and safety of non-pharmacological therapies for the treatment of inflammatory bowel disease: a network meta-analysis.

Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, causes chronic inflammation in the digestive tract that can lead to serious complications if not properly managed. Researchers analyzed 62 clinical trials to compare different non-drug treatments for IBD, including acupuncture and moxibustion, dietary changes, fecal transplants, exercise, and behavioral therapy. The study used a sophisticated statistical method called network meta-analysis to determine which treatments worked best for different outcomes. The results showed that acupuncture and moxibustion (a traditional Chinese medicine technique where herbs are burned near the skin) was particularly effective for achieving clinical remission and relieving symptoms in IBD patients. This ancient therapy appeared to work by reducing inflammatory markers like TNF-alpha and improving intestinal health. Dietary interventions performed best at maintaining remission once achieved and reducing fecal calprotectin (an inflammation marker), while fecal microbiota transplantation was most effective at lowering C-reactive protein levels and ranked second for inducing remission. As expected, standard medical therapy still showed the highest probability for inducing remission, but these non-drug approaches offer valuable complementary options. For IBD patients seeking alternatives or additions to their current treatment plan, acupuncture and moxibustion shows promise based on this comprehensive analysis. The researchers noted that while these results are encouraging, more high-quality clinical trials are needed to strengthen the evidence. If you're considering acupuncture for IBD management, consult with a licensed acupuncturist experienced in treating gastrointestinal conditions.

This network meta-analysis evaluated non-pharmacological therapies for IBD across 62 randomized controlled trials sourced from multiple databases. Interventions compared included acupuncture and moxibustion (APMX), dietary interventions (DI), fecal microbiota transplantation (FMT), physical training, and cognitive behavioral therapy against standard medical therapy. Outcomes measured included clinical remission rates, disease activity, quality of life, and serum biomarkers (fecal calprotectin and C-reactive protein). Risk ratios for dichotomous outcomes and standardized mean differences for continuous variables were calculated with 95% credible intervals. APMX demonstrated the highest efficacy among non-pharmacological interventions for inducing clinical remission and symptom relief, with evidence suggesting reduction in serum TNF-α levels and improved intestinal health. DI ranked first for maintaining clinical remission and reducing fecal calprotectin, while FMT was most effective for reducing CRP levels and ranked second for remission induction. Quality assessment used Cochrane and GRADE methodologies. Clinical implication: APMX represents a viable adjunctive treatment option for IBD management, particularly for patients seeking complementary approaches to conventional therapy.